Assessment of Medication Adherence in a Cohort of Patients with Bipolar Disorder

Abstract

Introduction: This study aimed to identify factors associated with medication adherence in bipolar disorder (BPD) patients.

Methods: EMBLEM is a 2-year, prospective, observational study on the outcomes of BPD patients initiating or changing treatment for a manic/mixed episode. Data were collected at baseline, during the first 12 weeks of treatment (acute phase) and up to 24 months of follow-up (maintenance phase). Adherence was assessed by investigators at every visit. Repeated measures logistic regression analyses identified variables associated with adherence.

Results: Of 1 831 patients included in the analysis, 76.6% were adherent and 23.4% were non-adherent with their BPD medication during the maintenance phase. Patients were more likely to be adherent if they had insight into their illness at week 12. Patients were less likely to be adherent if they had cannabis abuse/dependence during the acute phase, work impairment or higher CGI hallucinations/delusions at baseline

Discussion: Psychotic symptoms, poor insight, cannabis abuse/dependence and work impairment are negatively related to medication adherence during maintenance therapy of bipolar disorder. Patients with these characteristics may need a different therapeutic approach.

References

• 1 Azorin JM, Kaladjian A, Adida M. et al . Toward the delineation of mania subtypes in the French National EPIMAN-II Mille Cohort: Comparisons with prior cluster analytic investigations.  Eur Arch Psychiatry Clin Neurosci. 2008;  258 497-504
• 2 Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients.  Hum Psychopharmacol Clin Exp. 2008;  23 95-105
• 3 Baldessarini RJ, Salvatore P, Tohen M. et al . Morbidity from onset in first-episode bipolar I disorder patients: The International 300 Study [abstract].  Neuropsychopharmacology. 2004;  29 (Suppl. 1) S88
• 4 Brodersen A, Licht RW, Vestergaard P. et al . [Mortality in patients with affective disorder who commenced treatment with lithium. A 16-year follow-up].  Ugeskr Laeger. 2001;  163 6428-6432
• 5 Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis.  Acta Psychiatr Scand. 2002;  106 286-290
• 6 Coletti DJ, Leigh E, Gallelli KA. et al . Patterns of adherence to treatment in adolescents with bipolar disorder.  J Child Adolesc Psychopharmacol. 2005;  15 913-917
• 7 Colom F, Vieta E, Martínez-Arán A. et al . Clinical factors associated with treatment noncompliance in euthymic bipolar patients.  J Clin Psychiatry. 2000;  61 549-555
• 8 Copeland LA, Zeber JE, Salloum IM. et al . Treatment adherence and illness insight in veterans with bipolar disorder.  J Nerv Ment Dis. 2008;  196 16-21
• 9 Conrod P, Castellanos-Ryan N, Strang J. Brief, personality-targeted coping skills interventions and survival as a non-drug user over a 2-year period.  Arch Gen Psychiatry. 2010;  67 85-93
• 10 Crumlish N, Whitty P, Kamali M. et al . Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder.  Acta Psychiatr Scand. 2005;  112 449-455
• 11 DelBello MP, Hanseman D, Adler CM. et al . Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode.  Am J Psychiatry. 2007;  164 582-590
• 12 Dion GL, Tohen M, Anthony WA. et al . Symptoms and functioning of patients with bipolar disorder six months after hospitalization.  Hosp Community Psychiatry. 1988;  39 652-657
• 13 DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research.  Med Care. 2004;  42 200-209
• 14 Fagiolini A, Kupfer DJ, Rucci P. et al . Suicide attempts and ideation in patients with bipolar I disorder.  J Clin Psychiatry. 2004;  65 509-514
• 15 Fennig S, Everett E, Bromet EJ. et al . Insight in first-admission psychotic patients.  Schizophr Res. 1996;  22 257-263
• 16 Gazalle FK, Frey BN, Hallal PC. et al . Mismatch between self-reported quality of life and functional assessment in acute mania: a matter of unawareness of illness?.  J Affect Disord. 2007;  103 247-252
• 17 Ghaemi SN, Rosenquist KJ. Is insight in mania state-dependent?: A meta-analysis.  J Nerv Ment Dis. 2004;  192 771-775
• 18 Goetz I, Tohen M, Reed C. et al . EMBLEM Advisory Board. Functional impairment in patients with mania: baseline results of the EMBLEM study.  Bipolar Disord. 2007;  9 45-52
• 19 Gonzalez-Pinto A, Ballesteros J, Aldama A. et al . Principal components of mania.  J Affect Disord. 2003;  76 95-102
• 20 Gonzalez-Pinto A, Mosquera F, Alonso M. et al . Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.  Bipolar Disord. 2006;  8 (5 Pt 2) 618-624
• 21 Gonzalez-Pinto A, Mosquera F, Reed C. et al . Validity and reliability of the Hamilton Depression Rating Scale (5 items) for manic and mixed bipolar disorders.  J Nerv Ment Dis. 2009;  197 682-686
• 22 Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press; 1990
• 23 Haro JM, Van Os J, Vieta E. et al . Evidence for three distinct classes of ‘typical’, ‘psychotic’ and ‘dual’ mania: results from the EMBLEM study.  Acta Psychiatr Scand. 2006;  113 112-120
• 24 Joffe RT, MacQueen GM, Marriott M. et al . A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I and bipolar II disorders.  Bipolar Disord. 2004;  6 62-66
• 25 Johnson RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization.  Am J Psychiatry. 1996;  153 993-1000
• 26 Judd LL, Akiskal HS, Schettler PJ. et al . The long-term natural history of the weekly symptomatic status of bipolar I disorder.  Arch Gen Psychiatry. 2002;  59 530-537
• 27 Keck Jr PE, McElroy SL, Strakowski SM. et al . Factors associated with pharmacologic noncompliance in patients with mania.  J Clin Psychiatry. 1996;  57 292-297
• 28 Keck Jr PE, McElroy SL, Strakowski SM. et al . Outcome and comorbidity in first- compared with multiple-episode mania.  J Nerve Ment Dis. 1995;  183 320-324
• 29 Keck Jr PE, McElroy SL, Strakowski SM. et al . 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode.  Am J Psychiatry. 1998;  155 646-652
• 30 Keller MB, Lavori PW, Kane JM. et al . Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium.  Arch Gen Psychiatry. 1992;  49 371-376
• 31 Lewis M, Scott J, Frangou S. Impulsivity, personality and bipolar disorder.  Eur Psychiatry. 2009;  24 464-469
• 32 Manwani SG, Szilagyi KA, Zablotsky B. et al . Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders.  J Clin Psychiatry. 2007;  68 1172-1176
• 33 Martinez-Aran A, Scott J, Colom F. et al . Treatment nonadherence and neurocognitive impairment in bipolar disorder.  J Clin Psychiatry. 2009;  70 1017-1023
• 34 Merikangas KR, Herrell R, Swendsen J. et al . Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study.  Arch Gen Psychiatry. 2008;  65 47-52
• 35 Novick D, Haro JM, Suarez D. et al . Predictors and consequences of adherence with antipsychotic medication in the outpatient treatment of schizophrenia.  Psychiatry Res. 2009;  in press [doi:10.1016/j.psychres.2009.05.004]
• 36 Osby U, Brandt L, Correia N. et al . Excess mortality in bipolar and unipolar disorder in Sweden.  Arch Gen Psychiatry. 2001;  58 844-850
• 37 Post RM, Denicoff KD, Leverich GS. et al . Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.  J Clin Psychiatry. 2003;  64 680-690
• 38 Post RM, Leverich GS, Altshuler L. et al . Lithium-discontinuation-induced refractoriness: preliminary observations.  Am J Psychiatry. 1992;  149 1727-1729
• 39 Remington G, Kwon J, Collins A. et al . The use of electronic monitoring (MEMS^®) to evaluate antipsychotic compliance in outpatients with schizophrenia.  Schizophr Res. 2007;  90 229-237
• 40 Ringen PA, Lagerberg TV, Birkenæs AB. et al . Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.  Psychol Med. 2008;  38 1241-1249
• 41 Sajatovic M, Valenstein M, Blow FC. et al . Treatment adherence with antipsychotic medications in bipolar disorder.  Bipolar Disord. 2006;  8 232-241
• 42 Schumann C, Lenz G, Berghofer A. et al . Nonadherence with long-term prophylaxis: Six-year naturalistic follow-up study of affectively ill patients.  Psychiatry Res. 1999;  89 247-257
• 43 Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization.  Am J Psychiatry. 2002;  159 1927-1929
• 44 Spearing MK, Post RM, Leverich GS. et al . Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP.  Psychiatry Res. 1997;  73 159-171
• 45 Strakowski SM, DelBello MP, Fleck DE. et al . The impact of substance abuse on the course of bipolar disorder.  Biol Psychiatry. 2000;  48 477-485
• 46 Strakowski SM, DelBello MP, Fleck DE. et al . Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.  Arch Gen Psychiatry. 2007;  64 57-64
• 47 Strakowski SM, Fleck DE, DelBello MP. et al . Impulsivity across the course of bipolar disorder.  Bipolar Disord. 2010;  12 285-297
• 48 Strakowski SM, Keck Jr PE, McElroy SL. et al . Twelve-month outcome after a first hospitalization for affective psychosis.  Arch Gen Psychiatry. 1998;  55 49-55
• 49 Suppes T, Baldessarini RJ, Faedda GL. et al . Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.  Arch Gen Psychiatry. 1991;  48 1082-1088
• 50 Swann AC. Impulsivity in mania.  Current Psychiatry Reports. 2009;  11 481-487
• 51 Swann AC, Dougherty DM, Pazzaglia PJ. et al . Impulsivity: a link between bipolar disorder and substance abuse.  Bipolar Disord. 2004;  6 204-212
• 52 Tondo L, Baldessarini RJ, Hennen J. et al . Lithium treatment and risk of suicidal behaviour in bipolar disorder patients.  J Clin Psychiatry. 1998;  59 405-414
• 53 Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention.  CNS Drugs. 2003;  17 491-511
• 54 Vieta E. Improving treatment adherence in bipolar disorder through psychoeducation.  J Clin Psychiatry. 2005;  66 (Suppl. 1) 24-29
• 55 Yen CF, Chen CS, Ko CH. et al . Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.  Psychiatry Clin Neurosci. 2005;  59 403-409
• 56 Yen CF, Chen CS, Ko CH. et al . Changes in insight among patients with bipolar I disorder: a 2-year prospective study.  Bipolar Disord. 2007;  9 238-242
• 57 Young RC, Biggs JT, Ziegler VE. et al . A rating scale for mania: reliability, validity and sensitivity.  Br J Psychiatry. 1978;  133 429-435
• 58 Zeber JE, Copeland LA, Good CB. et al . Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder.  J Affect Disord. 2008;  107 53-62

Correspondence